Skip to content

Systemic Cross-talk Between Brain, Gut, and Peripheral Tissues in Glucose Homeostasis: Effects of Exercise Training

Modelling Systemic Cross-talk Between Brain, Gut, and Peripheral Tissues in Glucose Homeostasis: Exercise Training and Public Health

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03730610
Acronym
CROSSYS
Enrollment
24
Registered
2018-11-05
Start date
2019-01-30
Completion date
2021-10-31
Last updated
2022-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Exercise Training, Insulin Resistance, Obesity, Type2 Diabetes

Brief summary

Obesity and insulin resistance are worldwide epidemic and taking a major public health toll. Obesity also increases the risk for cognitive impairment which is also an increasing medical, societal, and economic challenge. The ultimate goal of this proposal is to develop a statistical model to assess systemic cross-talk between brain, peripheral tissues, gut microbiota and glucose metabolism. Integrated with exercise training intervention the results will be utilized to provide disease risk profiling and personalized predictions of exercise training as a drug free treatment for insulin resistance and type 2 diabetes.

Interventions

BEHAVIORALExercise training

Subjects are required to exercise four times a week during six months. Exercise training consists of endurance training, resistance training and high-intensity interval training adjusted to subject's fitness level.

Sponsors

University of Helsinki
CollaboratorOTHER
University of Eastern Finland
CollaboratorOTHER
Turku University Hospital
CollaboratorOTHER_GOV
Academy of Finland
CollaboratorOTHER
Finnish Cultural Foundation
CollaboratorOTHER
Diabetes Research Foundation, Finland
CollaboratorOTHER
Juho Vainio Foundation
CollaboratorOTHER
University of Turku
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Intervention model description

Exercise Training for six months

Eligibility

Sex/Gender
ALL
Age
30 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

* monozygotic twins * body mass index (BMI) difference ≥ 2 kg/m2 and/or type 2 diabetes * At least one co-twin is overweight (BMI \> 25 kg/m2)

Exclusion criteria

* BMI \> 60 kg/m2 * body weight \> 170 kg * waist circumference \> 150 cm * mental disorder or poor compliance * eating disorder or excessive use of alcohol * active ulcus disease * diabetes requiring insulin treatment or fasting glucose \> 10 mmol/l * pregnancy * past dose of radiation * claustrophobia * presence of ferromagnetic objects that would make MRI contraindicated

Design outcomes

Primary

MeasureTime frameDescription
Effects of exercise training - brain glucose uptakeThe change from baseline to 6 monthsBrain glucose uptake (micromol/100g/min) is measured with positron emission tomography (PET) with \[18F\]-labelled fluoro-deoxy-glucose (FDG) tracer.
Effects of exercise training - brain inflammationThe change from baseline to 6 monthsBrain inflammation (dimensionless; standistibution volume ratio) is measured with positron emission tomography (PET) with PK11195 tracer

Secondary

MeasureTime frameDescription
Effects of exercise training - liver glucose uptakeThe change from baseline to 6 monthsLiver glucose uptake (micromol/100g/min) is measured with positron emission tomography (PET) with \[18F\]-labelled fluoro-deoxy-glucose (FDG) tracer
Effects of exercise training - adipose tissue glucose uptakeThe change from baseline to 6 monthsAdipose tissue glucose uptake (micromol/100g/min) is measured with positron emission tomography (PET) with \[18F\]-labelled fluoro-deoxy-glucose (FDG) tracer
Effects of exercise training - whole-body insulin sensitivityThe change from baseline to 6 monthsWhole-body insulin sensitivity (M-value; micromol/100g/min) during the hyperinsulinemic euglycemic clamp
Effects of exercise training - ectopic fatThe change from baseline to 6 monthsEctopic fat content (%) is measured using magnetic resonance spectroscopy (MRS)

Countries

Finland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 16, 2026